Questions about this study?
The HopeStage team will email you.
WithdrawnNCT00458445
A Study of SPD465 in Young Adult Drivers With Attention-Deficit Hyperactivity Disorder (ADHD) Using Driving Simulators
This study evaluates the safety and effectiveness of SPD465 for people with ADHD.
Medication studyAges 19–25United States
Understand this study
What is this study about?
This study evaluates the safety and effectiveness of SPD465 for people with ADHD.
Who could participate?
This study is for people with ADHD. Listed age limits: 19 years to 25 years. Other eligibility criteria apply.
- Listed locations
- TampaSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: April 30, 2007
- Recruitment status
- Withdrawn
- Enrollment listed in the registry
- 0
- Sponsor
- Shire
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug, OTHER
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 19 Years to 25 Years
- Official registry ID
- NCT00458445
- Official title
Show the full official title
A Phase IIIb Study to Evaluate the Efficacy and Time Course of Treatment With SPD465 Compared to Placebo on Simulated Driving Safety and Performance in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)
Recruitment & locations
WithdrawnTampa
A listed location does not confirm current availability.
Questions about this study
What is this study about?
This study evaluates the safety and effectiveness of SPD465 for people with ADHD.
Who is behind this study?
The study sponsor is Shire.
Does this study involve medication?
Yes. The study involves medication, including SPD465.
Who can participate?
This study is for people with ADHD. Listed age limits: 19 years to 25 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as withdrawn.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me